Comparative Bioavailability of Ranitidine Tablets in Healthy Volunteers

How to Cite:Reza AboofazeliAlireza ShafaatiComparative Bioavailability of Ranitidine Tablets in Healthy Volunteers.Iran J Pharm Res.1(1):e129835.https://doi.org/10.22037/ijpr.2010.2.

Abstract

The pharmacokinetic parameters of domestic and imported ranitidine hydrochloride tablets (Ranitidine, formulated and manufactured by Kharazmi Pharmaceuticals, Iran, and Zantac^® manufactured by Glaxo, UK) were measured in 14 healthy subjects following oral administration of a single 300-mg dose of each brand and compared for bioequivalence evaluation.

The pharmaceutical equivalency of both formulations was shown by in vitro characterization and dissolution testing. The comparative bioavailability of the two products was then determined in a single-blind, single dose, randomized, cross-over study in 14 healthy volunteers. A sensitive, rapid and precise high performance liquid chromatography (HPLC) method was used to measure concentrations of ranitidine in plasma samples collected up to 12 hours following each dose. Pharmacokinetic parameters, including C_max, T_max, AUC_0-t, AUC_0-_¥ , elimination rate constant (k) and half life were determined for both formulations.

Analysis of the data revealed that the variations in all pharmacokinetic parameters were not statistically significant (p> 0.05), and the 90% confidence intervals for the test/reference mean ratios of the plasma pharmacokinetic variables lie within the conventional bioequivalence range of 80-125%. Therefore, both formulations were comparable based on the in vitro characterization and were bioequivalent in terms of Cmax and AUC.

The two formulations were considered to be bioequivalent.

Keywords

HPLC Detection

Zantac®

Ranitidine

Pharmacokinetic parameters

Comparative bioavailability

Bioequivalent

comments

Crossmark

Checking

Share on

Comments

Number of Comments:0

Cited by

Metrics

Get Permission (article level)

Purchasing Reprints

Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here ( https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.

Search Relations

Author(s):

Reza Aboofazeli:[PubMed][Scholar]
Alireza Shafaati:[PubMed][Scholar]